Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/56803
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShen J.-
dc.coverage.spatialMonash Medical Centre-
dc.date.accessioned2025-12-23T22:38:40Z-
dc.date.available2025-12-23T22:38:40Z-
dc.date.issued2019-12-09-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/56803-
dc.description.abstractDifferentiation between bilateral and unilateral (aldosterone-producing adenoma, APA) causes of primary aldosteronism (PA) relies on CT imaging of the adrenal glands and adrenal vein sampling (AVS), the latter of which is the current gold standard. CT imaging is limited by a high rate of adrenal incidentalomas, which can lead to dilemmas in management and pursuance of extensive investigations. AVS is operator dependent, labour intensive, expensive and invasive, also posing the risk of a failed or inconclusive study. We conduct this pilot prospective study in adults with confirmed PA with the objective of evaluating the efficacy of 68Ga-PentixaFor PET-CT in determining if an adrenal adenoma is the cause for primary aldosteronism, compared to AVS as the gold standard.-
dc.titleIdentification of aldosterone-producing adenomas using [68Ga]Ga-PentixaFor PET/CT-
dc.typeClinical trial-
dc.identifier.affiliationEndocrinology-
dc.description.publicationstatusPhase 3-
dc.identifier.urlhttps://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378863-
dc.identifier.externalACTRN12619001738112-
item.openairetypeClinical trial-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Clinical Trials
Show simple item record

Page view(s)

42
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.